Insulin Glulisine: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Insulin Glulisine. Educational only — not medical advice.
Labeled uses
APIDRA is indicated to improve glycemic control in adult and pediatric patients with diabetes mellitus.
Source: FDA labeling via NIH DailyMed (set e7af6a7a…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.